← Leaderboards
Charles Garrison Fathman
Stanford University
$27,441,596
Attributed
$27,441,596
Total exposure
25
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.9M · FY2005–21$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$41,848,921 · 28
By mechanism
U19$12,992,816 · 9
P01$9,818,054 · 4
R01$7,227,076 · 4
RC4$3,495,470 · 1
U01$2,793,544 · 2
T32$2,458,420 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Leonore A. Herzenberg$9,571,047
Others in their field
Top investigators on “Autoimmunity”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$303,553,812
- Barton F Haynes · Duke University$175,178,961
- Jeffrey P Krischer · University Of South Florida$145,926,425
- Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason$84,342,024
- Mark S Anderson · University Of California, San Francisco$69,470,335
- Robert S Negrin · Stanford University$48,464,292
Research focus
AutoimmunityPathway InteractionsImmunotherapyGene ExpressionT-LymphocyteFundingLaboratory MouseCellsTissuesAutoimmune DiseasesGenetically Modified AnimalsAnergyGenesInsightGene TherapyImmuneImmunoregulationTransfectionHuman DiseasePhenotypeProteinsResearch PersonnelTechnologyCd4 Positive T Lymphocytes
Grant awards (111)
Whole blood gene expression to identify biomarkers of disease risk, progression and response to therapy in Type 1 diabetes$432,984
R01 · FY2021 · DK · contact PI
Whole blood gene expression to identify biomarkers of disease risk, progression and response to therapy in Type 1 diabetes$432,984
R01 · FY2020 · DK · contact PI
Whole blood gene expression to identify biomarkers of disease risk, progression and response to therapy in Type 1 diabetes$432,984
R01 · FY2019 · DK · contact PI
Whole blood gene expression to identify biomarkers of disease risk, progression and response to therapy in Type 1 diabetes$432,984
R01 · FY2018 · DK · contact PI
Autoimmunity Center of Excellence (ACE) at Stanford$622,641
U19 · FY2013 · AI · contact PI
Deaf1 isoforms control changes in PTA expression in the NOD PLN during T1D pathog$372,735
R01 · FY2013 · AI · contact PI
Training Program in Adult and Pediatric Rheumatology$352,082
T32 · FY2013 · AR · contact PI
Ternary complex that drives T cell activation$255,607
R01 · FY2013 · CA · contact PI
Control of CD4 T Cell Unresponsiveness$247,565
U19 · FY2013 · AI · contact PI
Administrative Core$141,240
U19 · FY2013 · AI · contact PI
Autoimmunity Center of Excellence (ACE) at Stanford$670,355
U19 · FY2012 · AI · contact PI
Deaf1 isoforms control changes in PTA expression in the NOD PLN during T1D pathog$396,431
R01 · FY2012 · AI · contact PI
Ternary complex that drives T cell activation$265,394
R01 · FY2012 · CA · contact PI
Control of CD4 T Cell Unresponsiveness$257,337
U19 · FY2012 · AI · contact PI
Administrative Core$165,291
U19 · FY2012 · AI · contact PI
Autoimmunity Center of Excellence (ACE) at Stanford$685,303
U19 · FY2011 · AI · contact PI
Regulatory T cells in Autoimmune Disease$473,150
U19 · FY2011 · AI · contact PI
Deaf1 isoforms control changes in PTA expression in the NOD PLN during T1D pathog$396,339
R01 · FY2011 · AI · contact PI
Training Program in Adult and Pediatric Rheumatology$384,401
T32 · FY2011 · AR · contact PI
Immunoregulation of Autoimmunity$329,581
U01 · FY2011 · DK · contact PI
Ternary complex that drives T cell activation$277,790
R01 · FY2011 · CA · contact PI
Control of CD4 T Cell Unresponsiveness$254,880
U19 · FY2011 · AI · contact PI
Administrative Core$175,544
U19 · FY2011 · AI · contact PI
Immunobiology of Aging$3,495,470
RC4 · FY2010 · AG · contact PI
Autoimmunity Center of Excellence (ACE) at Stanford$701,037
U19 · FY2010 · AI · contact PI
Regulatory T cells in Autoimmune Disease$490,772
U19 · FY2010 · AI · contact PI
Deaf1 isoforms control changes in PTA expression in the NOD PLN during T1D pathog$415,252
R01 · FY2010 · AI · contact PI
Immunoregulation of Autoimmunity$329,881
U01 · FY2010 · DK · contact PI
Control of CD4 T Cell Unresponsiveness$261,405
U19 · FY2010 · AI · contact PI
Administrative Core$178,227
U19 · FY2010 · AI · contact PI
Autoimmunity Center of Excellence (ACE) at Stanford$707,559
U19 · FY2009 · AI · contact PI
Regulatory T cells in Autoimmune Disease$502,820
U19 · FY2009 · AI · contact PI
Training Program in Adult and Pediatric Rheumatology$382,878
T32 · FY2009 · AR · contact PI
Immunoregulation of Autoimmunity$322,013
U01 · FY2009 · DK · contact PI
Control of CD4 T Cell Unresponsiveness$264,500
U19 · FY2009 · AI · contact PI
Administrative Core$178,563
U19 · FY2009 · AI · contact PI
Autoimmunity Center of Excellence (ACE) at Stanford$49,328
U19 · FY2009 · AI · contact PI
Autoimmunity: Mechanisms of Unresponsiveness$1,009,020
P01 · FY2008 · AI · contact PI
Regulatory T cells in Autoimmune Disease$528,485
U19 · FY2008 · AI · contact PI
Training Program in Adult and Pediatric Rheumatology$372,317
T32 · FY2008 · AR · contact PI
Immunoregulation of Autoimmunity$314,391
U01 · FY2008 · DK · contact PI
Mechanisms of Adoptive Cellular Gene Therapy$307,820
P01 · FY2008 · AI · contact PI
Ternary Complex that Drives T Cell Activation$275,622
R01 · FY2008 · CA · contact PI
CORE--Animal Core$192,953
P01 · FY2008 · AI · contact PI
FOCIS New Investigator Travel Awards (2004-2008)$28,000
R13 · FY2008 · AI · contact PI
Autoimmunity: Mechanisms of Unresponsiveness$1,002,938
P01 · FY2007 · AI · contact PI
Regulatory T cells in Autoimmune Disease$524,244
U19 · FY2007 · AI · contact PI
Training Program in Adult and Pediatric Rheumatology$379,276
T32 · FY2007 · AR · contact PI
Immunoregulation of Autoimmunity$313,050
U01 · FY2007 · DK · contact PI
Mechanisms of Adoptive Cellular Gene Therapy$305,965
P01 · FY2007 · AI · contact PI
Ternary Complex that Drives T Cell Activation$275,523
R01 · FY2007 · CA · contact PI
CORE--Animal Core$191,790
P01 · FY2007 · AI · contact PI
FOCIS New Investigator Travel Awards (2004-2008)$10,000
R13 · FY2007 · AI · contact PI
Autoimmunity: Mechanisms of Unresponsiveness$1,007,289
P01 · FY2006 · AI · contact PI
Regulatory T cells in Autoimmune Disease$509,877
U19 · FY2006 · AI · contact PI
Adoptive Cellular Gene Therapy in Type 1 Diabetes (T1D)$380,835
R33 · FY2006 · AI · contact PI
Training Program in Adult and Pediatric Rheumatology$376,827
T32 · FY2006 · AR · contact PI
Mechanisms of Adoptive Cellular Gene Therapy$314,686
P01 · FY2006 · AI · contact PI
Immunoregulation of Autoimmunity$312,433
U01 · FY2006 · DK · contact PI
Ternary Complex that Drives T Cell Activation$283,656
R01 · FY2006 · CA · contact PI
CORE--Animal Core$197,258
P01 · FY2006 · AI · contact PI
FOCIS New Investigator Travel Awards (2004-2008)$10,000
R13 · FY2006 · AI · contact PI
Autoimmunity: Mechanisms of Unresponsiveness$1,002,489
P01 · FY2005 · AI
Strategies for Prevention of Autoimmunity$934,000
U19 · FY2005 · DK
Adoptive Cellular Gene Therapy in Type 1 Diabetes (T1D)$390,000
R33 · FY2005 · AI
Mechanisms of Adoptive Cellular Gene Therapy$305,827
P01 · FY2005 · AI
Ternary Complex that Drives T Cell Activation$290,386
R01 · FY2005 · CA
Training Program in Adult and Pediatric Rheumatology$210,639
T32 · FY2005 · AR
CORE--Animal Core$191,705
P01 · FY2005 · AI
CD25+ Regulator CD4+ T Cells$187,630
U01 · FY2005 · DK
FOCIS New Investigator Travel Awards (2004-2008)$10,000
R13 · FY2005 · AI
Autoimmunity: Mechanisms of Unresponsiveness$973,295
P01 · FY2004 · AI
Strategies for Prevention of Autoimmunity$909,292
U19 · FY2004 · DK
Adoptive Cellular Gene Therapy in Type 1 Diabetes (T1D)$392,500
R33 · FY2004 · AI
Mechanisms of Adoptive Cellular Gene Therapy$296,921
P01 · FY2004 · AI
Ternary Complex that Drives T Cell Activation$290,295
R01 · FY2004 · CA
CORE--Animal Core$186,122
P01 · FY2004 · AI
CD25+ Regulator CD4+ T Cells$182,622
U01 · FY2004 · DK
FOCIS New Investigator Travel Awards (2004-2008)$14,500
R13 · FY2004 · AI
International Congress of Immunology - Travel Awards$5,000
R13 · FY2004 · AI
Strategies for Prevention of Autoimmunity$885,307
U19 · FY2003 · DK
Adoptive Cellular Gene Therapy in Type 1 Diabetes (T1D)$280,348
R21 · FY2003 · AI
TERNARY COMPLEX THAT DRIVES T CELL ACTIVATION$264,846
R01 · FY2003 · CA
Novel Anergy Genes as Markers of Immune Tolerance$236,750
R21 · FY2003 · AI
CD25+ Regulator CD4+ T Cells$177,759
U01 · FY2003 · DK
Strategies for Prevention of Autoimmunity$880,068
U19 · FY2002 · DK
Adoptive Cellular Gene Therapy in Type 1 Diabetes (T1D)$262,954
R21 · FY2002 · AI
TERNARY COMPLEX THAT DRIVES T CELL ACTIVATION$258,084
R01 · FY2002 · CA
Novel Anergy Genes as Markers of Immune Tolerance$236,702
R21 · FY2002 · AI
CD25+ Regulator CD4+ T Cells$173,041
U01 · FY2002 · DK
FOCIS Annual Meetings (2002-2006)$41,000
R13 · FY2002 · AI
Pilo Studyt--MHC and Homing of DC to Joints in RA$0
U19 · FY2002 · DK
Notch/Notch Cell Fate Decision in Tolerance/Autoimmunity$0
U19 · FY2002 · DK
Gene Therapy to Prevent Autoimmune Disease$0
U19 · FY2002 · DK
AUTOIMMUNITY--MECHANISMS OF UNRESPONSIVENESS$797,914
P01 · FY2001 · AI
Strategies for Prevention of Autoimmunity$794,026
U19 · FY2001 · DK
IMMUNOTHERAPY IN DIABETES--THE NONOBESE DIABETIC MOUSE$344,829
R01 · FY2001 · DK
TERNARY COMPLEX THAT DRIVES T CELL ACTIVATION$251,521
R01 · FY2001 · CA
Novel Anergy Genes as Markers of Immune Tolerance$236,656
R21 · FY2001 · AI
GENE TRANSDUCTION OF T CELLS IN TREATMENT OF EAE$196,218
P01 · FY2001 · AI
CORE--ANIMAL FACILITY$196,218
P01 · FY2001 · AI
CD25+ Regulator CD4+ T Cells$151,143
U01 · FY2001 · DK
Gene Therapy to Prevent Autoimmune Disease$0
U19 · FY2001 · DK
Pilo Studyt--MHC and Homing of DC to Joints in RA$0
U19 · FY2001 · DK
Notch/Notch Cell Fate Decision in Tolerance/Autoimmunity$0
U19 · FY2001 · DK
AUTOIMMUNITY--MECHANISMS OF UNRESPONSIVENESS$775,464
P01 · FY2000 · AI
RETROVIRAL MEDIATED GENE THERAPY OF RHEUMATOID ARTHRITIS$528,296
N01 · FY2000 · AR
IMMUNOTHERAPY IN DIABETES--THE NONOBESE DIABETIC MOUSE$335,685
R01 · FY2000 · DK
TERNARY COMPLEX THAT DRIVES T CELL ACTIVATION$245,145
R01 · FY2000 · CA
CORE--ANIMAL FACILITY$183,081
P01 · FY2000 · AI
GENE TRANSDUCTION OF T CELLS IN TREATMENT OF EAE$183,081
P01 · FY2000 · AI